Canlyniadau Chwilio am Awdur

1

How I treat infant leukemia gan Patrick A. Brown, Rob Pieters, Andrea Biondi

Cyhoeddwyd 2018

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL gan Rob Pieters, Charles G. Mullighan, Stephen P. Hunger

Cyhoeddwyd 2023

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Myocyte enhancer factor 2C in hematopoiesis and leukemia gan Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia gan Rob Pieters, D. R. Huismans, A. Leyva, A. Veerman

Cyhoeddwyd 1989

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine gan Annelies Hartman, Cor van den Bos, Theo Stijnen, Rob Pieters

Cyhoeddwyd 2006

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment gan Roel Polak, Bob de Rooij, Rob Pieters, Monique L. den Boer

Cyhoeddwyd 2015

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia gan Pieter Van Vlierberghe, Rob Pieters, H. Berna Beverloo, Jules P.P. Meijerink

Cyhoeddwyd 2008

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia gan Rui D. Mendes, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Cyhoeddwyd 2016

Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation gan Robin Q.H. Kloos, Rob Pieters, Gabriele Escherich, Inge M. van der Sluis

Cyhoeddwyd 2016

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche gan Bob de Rooij, Roel Polak, Femke Stalpers, Rob Pieters, Monique L. den Boer

Cyhoeddwyd 2017

Cael y testun llawn Cael y testun llawn
Carta

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia gan Trudy Buitenkamp, Ron A. A. Mathôt, Valérie de Haas, Rob Pieters, C. Michel Zwaan

Cyhoeddwyd 2010

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective gan Judith M. de Bont, Roger J. Packer, Erna Michiels, Monique L. den Boer, Rob Pieters

Cyhoeddwyd 2008

Cael y testun llawn Cael y testun llawn
Revisão

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study gan Gertjan J.L. Kaspers, LA Smets, Rob Pieters, CH Van Zantwijk, ER van Wering, A. Veerman

Cyhoeddwyd 1995

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia gan Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Gritta Janka‐Schaub, Rob Pieters

Cyhoeddwyd 2003

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions gan Rob Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, MW Heyenbrok, K. Hählen, A. Veerman

Cyhoeddwyd 1990

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
16

Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia gan Ronald W. Stam, Pauline Schneider, Paola De Lorenzo, Maria Grazia Valsecchi, Monique L. den Boer, Rob Pieters

Cyhoeddwyd 2007

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
17

MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations gan Mark Kerstjens, Emma M. C. Driessen, Merel Willekes, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam

Cyhoeddwyd 2016

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
18

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies gan Valentina Cordo’, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Cyhoeddwyd 2020

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
19

MLL fusion-driven activation ofCDK6potentiates proliferation inMLL-rearranged infant ALL gan Marieke van der Linden, Merel Willekes, Eddy van Roon, Lidija Seslija, Pauline Schneider, Rob Pieters, Ronald W. Stam

Cyhoeddwyd 2014

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
20

Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia gan Inge M. Appel, Monique L. den Boer, Jules P.P. Meijerink, A. Veerman, Nathalie C. M. Reniers, Rob Pieters

Cyhoeddwyd 2006

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

How I treat infant leukemia gan Patrick A. Brown, Rob Pieters, Andrea Biondi

Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL gan Rob Pieters, Charles G. Mullighan, Stephen P. Hunger

Myocyte enhancer factor 2C in hematopoiesis and leukemia gan Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia gan Rob Pieters, D. R. Huismans, A. Leyva, A. Veerman

Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine gan Annelies Hartman, Cor van den Bos, Theo Stijnen, Rob Pieters

B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment gan Roel Polak, Bob de Rooij, Rob Pieters, Monique L. den Boer

Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia gan Pieter Van Vlierberghe, Rob Pieters, H. Berna Beverloo, Jules P.P. Meijerink

The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia gan Rui D. Mendes, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation gan Robin Q.H. Kloos, Rob Pieters, Gabriele Escherich, Inge M. van der Sluis

Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche gan Bob de Rooij, Roel Polak, Femke Stalpers, Rob Pieters, Monique L. den Boer

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia gan Trudy Buitenkamp, Ron A. A. Mathôt, Valérie de Haas, Rob Pieters, C. Michel Zwaan

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective gan Judith M. de Bont, Roger J. Packer, Erna Michiels, Monique L. den Boer, Rob Pieters

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study gan Gertjan J.L. Kaspers, LA Smets, Rob Pieters, CH Van Zantwijk, ER van Wering, A. Veerman

Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia gan Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Gritta Janka‐Schaub, Rob Pieters

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions gan Rob Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, MW Heyenbrok, K. Hählen, A. Veerman

Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia gan Ronald W. Stam, Pauline Schneider, Paola De Lorenzo, Maria Grazia Valsecchi, Monique L. den Boer, Rob Pieters

MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations gan Mark Kerstjens, Emma M. C. Driessen, Merel Willekes, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies gan Valentina Cordo’, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

MLL fusion-driven activation of<i>CDK6</i>potentiates proliferation in<i>MLL-</i>rearranged infant ALL gan Marieke van der Linden, Merel Willekes, Eddy van Roon, Lidija Seslija, Pauline Schneider, Rob Pieters, Ronald W. Stam

Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia gan Inge M. Appel, Monique L. den Boer, Jules P.P. Meijerink, A. Veerman, Nathalie C. M. Reniers, Rob Pieters

Canlyniadau Chwilio - Rob Pieters

How I treat infant leukemia gan Patrick A. Brown, Rob Pieters, Andrea Biondi

Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL gan Rob Pieters, Charles G. Mullighan, Stephen P. Hunger

Myocyte enhancer factor 2C in hematopoiesis and leukemia gan Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia gan Rob Pieters, D. R. Huismans, A. Leyva, A. Veerman

Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine gan Annelies Hartman, Cor van den Bos, Theo Stijnen, Rob Pieters

B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment gan Roel Polak, Bob de Rooij, Rob Pieters, Monique L. den Boer

Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia gan Pieter Van Vlierberghe, Rob Pieters, H. Berna Beverloo, Jules P.P. Meijerink

The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia gan Rui D. Mendes, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation gan Robin Q.H. Kloos, Rob Pieters, Gabriele Escherich, Inge M. van der Sluis

Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche gan Bob de Rooij, Roel Polak, Femke Stalpers, Rob Pieters, Monique L. den Boer

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia gan Trudy Buitenkamp, Ron A. A. Mathôt, Valérie de Haas, Rob Pieters, C. Michel Zwaan

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective gan Judith M. de Bont, Roger J. Packer, Erna Michiels, Monique L. den Boer, Rob Pieters

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study gan Gertjan J.L. Kaspers, LA Smets, Rob Pieters, CH Van Zantwijk, ER van Wering, A. Veerman

Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia gan Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Gritta Janka‐Schaub, Rob Pieters

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions gan Rob Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, MW Heyenbrok, K. Hählen, A. Veerman

Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia gan Ronald W. Stam, Pauline Schneider, Paola De Lorenzo, Maria Grazia Valsecchi, Monique L. den Boer, Rob Pieters

MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations gan Mark Kerstjens, Emma M. C. Driessen, Merel Willekes, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies gan Valentina Cordo’, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

MLL fusion-driven activation of<i>CDK6</i>potentiates proliferation in<i>MLL-</i>rearranged infant ALL gan Marieke van der Linden, Merel Willekes, Eddy van Roon, Lidija Seslija, Pauline Schneider, Rob Pieters, Ronald W. Stam

Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia gan Inge M. Appel, Monique L. den Boer, Jules P.P. Meijerink, A. Veerman, Nathalie C. M. Reniers, Rob Pieters

Offerynnau Chwilio:

Pynciau Perthynol